Advertisements


Mallinckrodt announces publication of results from Phase 1b trial of StrataGraft

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2019

TG Therapeutics announces publication of data from Phase I/Ib trial of U2

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 30th, 2019

FibroGen announces publication of results from Phase 2 study of pamrevlumab

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 30th, 2019

Eli Lilly announces results from Phase 3 MONARCH 2 clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 29th, 2019

Bristol-Myers announces five-year results from Phase 3 CheckMate -067 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 29th, 2019

Incyte announces updated results from Phase 2 FIGHT-202 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 27th, 2019

AzurRx BioPharma announces results from Phase 2 trial with MS1819

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 25th, 2019

Mallinckrodt says StrataGraft Phase 3 trial met both primary endpoints

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 23rd, 2019

Mallinckrodt"s stock soars after last-stage trial of StrataGraft tissues meets key targets

Shares of Mallinckrodt PLC soared 19% in premarket trading Monday, after the drugmaker said a phase 3 trial of its investigational StratGraft regenerative tissue met both primary endpoints of efficacy and safety. "R.....»»

Category: topSource: marketwatchSep 23rd, 2019

Durect completes Phase 2a trial of DUR-928 and announces results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 17th, 2019

Theravance Biopharma announces "positive" results from Phase 1 trial of TD-8236

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 9th, 2019

Kura Oncology announces results from Phase 2 trial of tipifarnib

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 3rd, 2019

AstraZeneca announces results from Phase 3 THEMIS trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 2nd, 2019

AstraZeneca announces detailed results from Phase 3 DAPA-HF trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 2nd, 2019

Mallinckrodt says StrataGraft to be evaluated in Phase 3 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2019

Kiniksa announces interim results from Phase 1b KPL-716 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 12th, 2019

Chiasma announces results from Phase 3 CHIASMA OPTIMAL clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 23rd, 2019

BioXcel Therapeutics announces results from adaptive Phase 1b trial of BXCL501

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 22nd, 2019

Bicycle Therapeutics announces topline results from THR-149 Phase I trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 1st, 2019

BioPharmX announces results from Phase 2b clinical trial of BPX-041

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2019

BeiGene announces updated results from Global Phase 1/2 trial of zanubrutinib

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2019